Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Clinical trial NCT07306949 · RECRUITING
Trial details
- NCT number
- NCT07306949
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2028-03-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.